Clinical Characterisation Protocol for Severe Emerging Infections
Latest Information Update: 01 Aug 2024
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Lopinavir/ritonavir (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms FrenchCOVID
- 30 Jul 2024 Status changed from recruiting to active, no longer recruiting.
- 24 Feb 2022 Planned primary completion date changed from 7 Aug 2020 to 7 Aug 2025.
- 22 Sep 2021 Planned End Date changed from 7 Aug 2023 to 7 Aug 2025.